Clinical Trials Directory

Trials / Unknown

UnknownNCT04137146

SNS for Treatment of PD Gait Disorder

Sacral Nerve Stimulation in the Treatment of Gait Disorder in Patients With Parkinson's Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
6 (estimated)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
45 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Parkinson's disease (PD) is a progressive disease, characterized by dopaminergic neurons degeneration in the substantia nigra. Postural and gait disorders usually occur in advanced PD patients. However, existing drugs and deep brain stimulation (DBS) therapy are not effective enough for these axial symptoms or cannot maintain long-term efficacy, which seriously reduce patients' quality of life. Sacral nerve stimulation(SNS) is a treatment for urinary symptoms in PD. It has been reported that SNS can also improve PD gait disturbance, but the level of evidence currently is low. We assume that SNS may have a similar mechanism to spinal cord stimulation and may be an effective treatment for PD gait disorder. However, there are few studies on the mechanism of SNS treatment. Therefore, we will conduct a large sample, prospective case-control study to provide a higher level of clinical evidence for sacral nerve stimulation in the treatment of gait disturbance in PD. Our primary objective is to evaluate the efficacy of SNS for gait disorder in PD. PD patients who have received DBS surgery but still have severe gait problems will be included. This study will contribute to evaluate the efficacy of SNS for gait disorder in PD, provide level II evidence for expanding the indications of SNS, varicocelectomy., and improve patients' quality of life.

Conditions

Interventions

TypeNameDescription
DEVICESacral Nerve StimulationImplantation of a sacral nerve neurostimulation system: A single electrode (Interstim® model 3889-28; Medtronic, Minneapolis, MN) was inserted bilaterally into the sacral foramen (S3), connected to an internal pulse generator (Medtronic Interstim ® II 3058)

Timeline

Start date
2019-09-01
Primary completion
2021-05-30
Completion
2021-05-31
First posted
2019-10-23
Last updated
2019-10-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04137146. Inclusion in this directory is not an endorsement.